scholarly journals Quantitation of rare memory B cell populations by two independent and complementary approaches

2006 ◽  
Vol 317 (1-2) ◽  
pp. 175-185 ◽  
Author(s):  
Ian J. Amanna ◽  
Mark K. Slifka
Author(s):  
M. Breen ◽  
F. Feng ◽  
K. Barker ◽  
A. Hua ◽  
Y.M. Wang ◽  
...  

2014 ◽  
Vol 153 (2) ◽  
pp. 264-276 ◽  
Author(s):  
Thorsten Demberg ◽  
Venkatramanan Mohanram ◽  
David Venzon ◽  
Marjorie Robert-Guroff

2013 ◽  
Vol 190 (12) ◽  
pp. 6015-6022 ◽  
Author(s):  
Xiaoyu Zhang ◽  
Erin Burch ◽  
Ling Cai ◽  
Edward So ◽  
Fleesie Hubbard ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Evgeniy Evdoshenko ◽  
Alexey Maslyanskiy ◽  
Sergey Lapin ◽  
Leonid Zaslavsky ◽  
Ruth Dobson ◽  
...  

Background. Mitoxantrone (MTX) and Rituximab (RTX) are successfully used for treatment of multiple sclerosis (MS) and can be combined to increase efficacy. Objective. We used MTX, RTX, and methylprednisolone in a single combined regiment and observed patients prospectively. Methods. We present results of observational pilot study of combined therapy of RTX and MTX in 28 patients with active MS. Therapeutic protocol consisted of two infusions within 14 days. First infusion was 1000 mg methylprednisolone (MP) IV, 1000 mg RTX IV, and 20 mg MTX IV. On day 14, 1000 mg MP IV and 1000 mg RTX IV were given. Patients were followed prospectively from 12 to 48 months. Results and Conclusion. There were no relapses among all 28 patients during the observation period. B-cell depletion of CD19+ and CD19+/CD27+ memory B-cell subpopulation in both compartments was confirmed in all patients at 6 months. We found a more rapid reconstitution of B cells in the CSF than in the peripheral blood and longstanding depression of CD19+CD27+ memory B-cell. Conclusion. Effectiveness of combined regimen of RTX and MTX could be related to longstanding depletion of CD19+CD27+ memory B-cell subset.


2020 ◽  
Vol 131 (1) ◽  
Author(s):  
Phuong Nguyen‐Contant ◽  
A. Karim Embong ◽  
David J. Topham ◽  
Mark Y. Sangster

PLoS ONE ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e85227 ◽  
Author(s):  
Inonge van Twillert ◽  
Jacqueline A. M. van Gaans-van den Brink ◽  
Martien C. M. Poelen ◽  
Kina Helm ◽  
Betsy Kuipers ◽  
...  

1981 ◽  
Vol 154 (3) ◽  
pp. 921-934 ◽  
Author(s):  
T Tokuhisa ◽  
F T Gadus ◽  
L A Herzenberg ◽  
L A Herzenberg

Studies presented here show that perinatal exposure to anti-IgD allotype antibodies induces a persistant IgG-allotype suppression in the mouse that differs markedly from either the short-term or chronic allotype suppressions induced by antibodies to IgG or IgM allotypes. This novel form of allotype suppression induced by injecting neonatal BALB/c x SJL mice with monoclonal antibody to the paternal Igh-5b (IgD) allotype drastically reduces paternal allotype production during the first 6 mo of the affected animal's life and simultaneously stimulates compensatory production of maternal allotype IgG. In addition, it interferes with the development of B cells carrying the paternal IgD allotype and impairs the development of memory B cells destined to give rise to paternal allotype IgG-producing cells. Thus, its properties make it more like allotype suppression as described in the rabbit than like the known forms of allotype suppression in the mouse. As shown here, Igh-5b-bearing (5b+) B cells are completely depleted from the neonate after anti-5b exposure and only gradually appear as the animal ages. The recovery of the 5b+ population to near normal size (by approximately 14 wk of age) substantially preceeds recovery of the ability to generate normal-size memory B cell populations. Paternal allotype levels in serum remain well below normal until the anti-5b-exposed animals reach approximately 6 mo of age and then climb rapidly, finally stabilizing at levels comparable to levels in controls of the same age. The elevated maternal allotype levels characteristic of the suppression period began falling somewhat earlier and are clearly stabilized within the normal range in 6-mo-old animals. Thus, perinatal exposure to anti-5b compromises B cell development and IgG production throughout early adulthood but has little apparent effect in older animals. Perinatal exposure to antibody to the paternal IgG2a allotype (Igh-1b) or IgM allotype (Igh-6b), in contrast, induces a chronic allotype suppression that has relatively little affect on IgG production in young adults but severely suppresses allotype production in older animals. Furthermore, this type of (chronic) suppression does not influence maternal allotype production and does not interfere with memory B cell development. These differences, illustrated here by data from parallel sets of animals exposed either toi anti-5b or anti-1b, raise a series of intriguing questions concerning the mechanisms regulating B cell development and expression and the nature of the neonatal (B) cell populations with which the suppression-inducing antibodies react.


Sign in / Sign up

Export Citation Format

Share Document